Basf Aktiengesellschaft

Basf Se Corporation

Basf Aktienegesellschaft

Basf Aktiengellsellschaft

Basf Akeiengesellschaft

Maximilian Angel

Karl Kolter

Joachim Pakusch

Axel Sanner

Andree Dragon

Wilhelm Friedrich Beckerle

Gernot Franzmann

Manfred Schwartz

Claudia Wood

Erich Penzel

Bernhard Dotzauer

Robert Rupaner

Wolfgang Reuther

Bernhard Hauer

Joachim Roser

Bernhard Schuler

Heinrich Sack

Eckehardt Wistuba

Rudolf Schuhmacher

Peter Hossel

Frank Hoefer

Hartwig Voβ

Karl-Heinz Schumacher

Ulrike Licht

Ivette Garcia Castro

Hartwig Voss

Klemens Mathauer

Thomas Schwerzel

Dieter Faul

Thomas Friedrich

Klaus Boehlke

Günter Scherr

Josef Neutzner

Karl Stork

Ortwin Schaffer

Volker Braig

Helmut Meffert

Bernhard Fussnegger

Juergen Weiser

Stefan Stein

Peter Weyland

Michael Klemens Mueller

Michael W Mueller

Alfred Leinenbach

Hans-Joachim Hähnle

Michael Gotsche

Silke Gebert

Felicitas Guth

Andreas Einwiller

Rolf Petri

Katrin Zeitz

Theo Smit

Karin Neubecker

Peter Claassen

Hermann Bergmann

Matthias Karl

Franz Matejcek

Lysander Chrisstoffels

Bernhard Linner

Frank Schmidt

Bernd De Potzolli

Wilma M Dausch

Peter Hoessel

Thomas Breiner

Karl Haberle

Brigitte Wegner

Peter Hössel

Martin Scholtissek

Peter Pfoehler

Nicolas Kokel

Kathrin Meyer-Böhm

Rolf Gulden

Simone Schillo

Helmut Teichmann

Tanja Schneider

Andreas Habich

Michael Klemens Müller

Klaus Schagerer

Rüdiger Füssl

Veronique Kessler

Maximilian Blochberger-Claus

Richard Kramer

Jeffrey Knight

Frank Höfer

Bernd Daeumer

Jan-Peter Mittwollen

Ferdinand Paul Brandl

Heiko Alexander Schiffter

Martin Rübenacker

Dietmar Häring

Nils Rottmann

Terpolymer, wherein 20 to 35% by weight of the structural units are derived from acrylic acid, 45 to 60% by weight of the structural units from a hydrophobic methacrylate selected from a group consisting of isopropyl methacrylate, tert-butyl methacrylate and cyclohexyl methacrylate and 15 to 40% by weight of the structural units from a third olefinic monomer selected from the group consisting of N-vinyl lactam, hydroxy ethyl methacrylate and phenoxyethyl acrylate with the proviso that the total amount of structural units derived from the three monomer groups adds up to 100% by weight, and the use of the terpolymers as crystallization inhibitors in pharmaceutical dosage forms for inhibiting the recrystallization in an aqueous environment of a human or animal body of an active ingredient.

Terpolymers and their use in pharmaceutical dosage forms

The use of powder-form, crosslinked, water-insoluble, low-swelling polyacrylates as disintegrants for solid pharmaceutical dosage forms.

Poly(meth)acrylic acid popcorn polymerizates as disintegrants for tablets

Pharmaceutical coatings obtained from coating compositions based on film-forming copolymers of N,N-diethylaminoethyl methacrylate (DEAEMA) and methyl methacrylate (MMA) comprising a weight ratio of DEAEMA:MMA in the range of 35:65 to 55:45, where the copolymers are present partially neutralized with C-C-dicarboxylic acids.

Production of pharmaceutical protective coatings with good resistance in a neutral environment

Described are solid dispersions of hydrophobic active ingredients and cationic copolymers of N,N-diethylaminoethyl methacrylate and methyl methacrylate in a weight ratio of the monomers of from 35:65 to 55:45. Also described are the preparation and use of such solid dispersions for pharmaceutical dosage forms.

Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers

Water-soluble polymeric salts of medicaments sparingly soluble in water consisting of a cationogenic medicament which, in uncharged form or as hydrochloride, has a solubility of less than 0.1% (m/m) in water, artificial intestinal juice or gastric juice, and an anionogenic water-soluble polymer having a solubility in water of at least 5% (m/m) in the pH range of 1 to 13 and which is obtained by free-radically initiated polymerization of a monomer mixture of i) 70 to 90% by weight N-vinylpyrrolidone and ii) 10 to 30% by weight acrylic acid, wherein the sum total of i) and ii) corresponds to 100% by weight.

Salts of active ingredients with polymeric counterions

Dosage forms provided with protective coatings in which a core comprising at least one acidic active ingredient is provided with at least one inner and one outer coating layer, where the outer layer comprises, as component A, a cationic polymer which is an emulsion polymer of N,N-diethylaminoethyl methacrylate and further monomers.

Protective coatings for acidic active ingredients

A rapidly dispersible, fine-particle film-coating composition which is in powder form and is not prone to segregation for coating pharmaceutical dosage forms, consisting of

Rapidly dispersible, fine-particle film-coating composition which is in powder form, is not prone to segregation and is based on polyvinyl alcohol-polyether graft copolymers characterized by particular physical stability and low asperity

The present invention relates to a process for preparing an aqueous polymer dispersion by free-radical emulsion polymerization of a monomer mixture which comprises N,N-diethylaminoethyl methacrylate, to the polymer dispersion obtainable by this process, and to the use thereof.

Aqueous polymer dispersion based on N,N-diethylaminoethyl methacrylate, its preparation and use

The present invention relates to the use of copolymers comprising N-vinylpyrrolidone and a hydrophobically modified acrylic acid derivative as agents for improving the water resistance of a cosmetic formulation, and to the use of these copolymers in sunscreen compositions for increasing the sun protection factor, and furthermore the present invention relates to cosmetic formulations comprising these copolymers.

Water-resistant cosmetic formulations comprising a hydrophobically modified vinylpyrrolidone copolymer

A coating material, containing a mixture of i) a polymer obtained by radical polymerization from a) N,N-diethylaminoethyl methacrylate, and b) at least one radically polymerizable compound, selected from esters of &#x3b1;,&#x3b2;-ethylenically unsaturated mono- and dicarboxylic acids with C-Calkanols, as component A, ii) one or more antioxidants as component B, iii) one or more plasticizers as component C, and iv) other excipients as components D, wherein the total amount of the mixture of components A-D is 100 wt. %.

Stable protective coatings for pharmaceutical dosage forms

Provided is a process for the preparation of methacrylate-based polymers soluble in aqueous medium, which can be used, in particular, as associative and non-associative thickeners.

Associative thickeners based on methacrylate

The present invention relates to a process for the preparation of polymers comprising carboxyl groups by emulsion polymerization and the use of the polymers obtainable by this process, for example as thickeners. Moreover, the invention relates to thickener dispersions obtainable by the process and to the use thereof for modifying the rheology of paper coating slips, textile printing pastes, drugs, cosmetic preparations, detergents, cleansing compositions, or foods.

Preparation of polyacrylates by emulsion polymerization

Described is a process for producing pulverulent, antioxidant-comprising coating compositions, comprising providing an aqueous polymer dispersions comprising one or more antioxidants and a polymer obtained by radical polymerization of

Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms

Described are processes for producing pulverulent coating compositions comprising providing an aqueous polymer dispersion comprising

Growing community of inventors

Schifferstadt, Germany

Maximilian Angel